Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of TD0015 Pilulae in Knee Osteoarthritis
NCT06657495Phase 2Recruiting
- Sponsor
- Sao Thai Duong Joint Stock Company
- Start
- Jul 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TD0015 in knee osteoarthritis (OA) (3 arms), sponsored by Sao Thai Duong Joint Stock Company. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index at Day 90, Visual Analog Scale Pain Score at Day 90 and 4 more. Started Jul 2021; status: recruiting.
02
Drugs
TD0015
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06657495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06657495.